Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line : Editorial to: "Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes" by N. Hammoudi et al.

ABSTRACT:

SUBMITTER: Gupte M 

PROVIDER: S-EPMC5717761 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature